Reuters logo
BRIEF-Biocartis Group and MRC Technology initiate development of liquid biopsy test for breast cancer
June 7, 2017 / 5:06 AM / in 4 months

BRIEF-Biocartis Group and MRC Technology initiate development of liquid biopsy test for breast cancer

June 7 (Reuters) - BIOCARTIS GROUP NV:

* REG-BIOCARTIS GROUP NV: MRC TECHNOLOGY AND BIOCARTIS INITIATE DEVELOPMENT OF LIQUID BIOPSY TEST FOR BREAST CANCER

* LUNG CANCER TEST MENU, IS EXPECTED TO BE LAUNCHED IN H2 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below